Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:45 PM
Ignite Modification Date:
2025-12-24 @ 10:45 PM
NCT ID:
NCT01847235
Eligibility Criteria:
Inclusion Criteria:
* Histologically proven anaplastic oligodendroglioma or oligoastrocytoma
* Progressed or relapsed after surgery or radiation therapy
* Female or male aged 20 years or over
* At least 1 measurable mass lesion
* ECOG performance status 0-3
* Adequate organ function
* absolute neutrophil count \> 1,500/μL
* platelet count \> 75,000/μL
* hemoglobin greater than 9 g/dL or 900g/L
* serum creatinine less than 1.5 times the upper limit of laboratory normal
* total serum bilirubin less than 1.5 times the upper limit of laboratory normal
* AST or ALT less than three times the upper limit of laboratory normal
Exclusion Criteria:
* Prior course of temozolomide
* Combined glioblastoma
* Pregnant woman
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT01847235
Study Brief:
Protocol Section:
NCT01847235